NEW YORK, Feb 1 (Reuters) - Mylan Laboratories Inc. said on Thursday that quarterly profit more than doubled, and reported better-than-expected sales, helped by its generic version of the Ditropan XL ...

Billionaire investor Carl Icahn has dropped his $5.39 billion offer to buy Mylan Laboratories Inc. and tendered his shares after regulators opened an investigation of a Mylan pain patch that was ...

Case Name: Bausch Health Ireland Ltd. v. Mylan Labs. Ltd., No. 21-10403 (SRC) (JSA), 2022 WL 683084 (D.N.J. Mar. 8, 2022) (Chesler, J.) Drug Product and Patent(s)-in ...

PITTSBURGH (AP) -- One of the world's largest generic drug makers, Mylan Laboratories Inc., will buy King Pharmaceuticals Inc. for $4 billion in stock as Mylan makes a stronger foray into the branded ...

SAN FRANCISCO (MarketWatch) -- Mylan Laboratories Inc. shares were down 12% at $20.20 in late afternoon trade Monday in what the company called an "overreaction" to the Food and Drug Administration's ...

Co announces that the FDA has granted final approval for Mylan Technologies' Supplemental Abbreviated New Drug Application for its 12 mcg/hr Fentanyl Transdermal System. This product is shipping ...

SAN FRANCISCO (MarketWatch) -- Mylan Laboratories Inc. and Forest Laboratories Inc.'s Forest Laboratories Holdings Ltd. said late Wednesday they have entered into an agreement for the ...